Advancing paediatric cancer care in Jordan: a strategic 10-year roadmap

Rawad Rihani1, Abdalla Awidi2, Maha Barbar1

  • 1Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan; School of Medicine, University of Jordan, Amman, Jordan.

Insights

This review identifies gaps in pediatric cancer care in Jordan and proposes a 10-year roadmap. The plan focuses on equitable, accessible, high-quality services, including early detection, treatment, and psychosocial support for children with cancer.

Area of Science:

  • Oncology
  • Public Health
  • Healthcare Management

Background:

  • Paediatric cancer care in Jordan faces significant gaps and challenges.
  • Optimal delivery of services requires a strategic, long-term approach.

Purpose of the Study:

  • To assess the current state of paediatric cancer care in Jordan.
  • To propose a 10-year roadmap with actionable solutions for improvement.
  • To outline a patient-centred approach prioritizing equitable and accessible care.

Main Methods:

  • A comprehensive review of paediatric cancer care landscape in Jordan.
  • Development of a 10-year roadmap by national experts in paediatric oncology and public health.
  • Emphasis on a holistic approach spanning the entire cancer care continuum.

Main Results:

  • Identification of crucial gaps, barriers, and challenges in paediatric cancer services.
  • A roadmap prioritizing capacity building, standardized treatment, and evidence-based practices.
  • Highlighting the need for innovative therapies, research, and workforce development.

Conclusions:

  • A consensus-driven monitoring system is proposed for sustainable implementation.
  • Community engagement is vital for cancer awareness and stigma reduction.
  • Advancing paediatric oncology services requires a multi-faceted, collaborative effort.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
146